Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia

1. Waanders, E.
2. Van Der Velden, V.H.J.
3. Van Der Schoot, C.E.
4. Van Leeuwen, F.N.
5. Van Reijmersdal, S.V.
6. De Haas, V.
7. Veerman, A.J.
8. Van Kessel, A.G.
9. Hoogerbrugge, P.M.
10. Kuiper, R.P.
11. Van Dongen, J.J.M.